Cencora, Inc. Overview
Pro stress-test →Cencora is a global pharmaceutical distribution company that connects manufacturers with healthcare providers while offering logistics, data analytics, and consulting services. The company reported first-quarter revenue of $85.9 billion for the period ended December 31, 2025, a 5.5 percent increase from the prior year.
Strategic Profile
Pro stress-test →Cencora is advancing its strategy through acquisitions that cement its position in specialty healthcare. The MSO strategy is a natural extension of Cencora's specialty provider relationships, with acquisitions of Retina Consultants of America and OneOncology providing two platform MSOs with significant capabilities.
Competitive Landscape
Pro stress-test →Cencora holds commanding market share in the US pharmaceutical wholesale industry alongside McKesson and Cardinal Health. The pharmaceutical wholesale industry is characterized by intense competition and consolidation, which could lead to pricing pressures and margin erosion.
Industry Context
Cencora, Inc. operates in Pharmaceutical Distribution & Healthcare Services.
Key facts
Founded: 1871 · Headquarters: Conshohocken, US · Revenue: $85.9B · Market cap: $69.95B